The new office is in Seacourt Tower in Botley, and it will accommodate more staff that will focus on developing the company's AI portfolio beyond stroke to indications such as lung fibrosis and cancer, it said. The office consists of more than 4,000 square feet (372 square meters) of space, the company noted.

Brainomix secures FDA clearance for stroke AI software
Artificial intelligence (AI) software developer Brainomix has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its flagship e-ASPECTS...

Blackford and Brainomix partner on AI for stroke care
Artificial intelligence (AI) software developers Blackford and Brainomix have established an agreement to integrate Brainomix's e-Stroke AI applications...

Brainomix and Visionable partner on stroke care
Clinical collaboration platform Visionable and artificial intelligence (AI) company Brainomix are working together to co-market their respective software...

Brainomix to collaborate with U.K. government on AI for lung cancer
U.K. artificial intelligence (AI) software developer Brainomix plans to collaborate with the National Consortium of Intelligent Medical Imaging (NCIMI)...

Brainomix, Bridge Biotherapeutics partner
U.K. artificial intelligence software developer Brainomix and Bridge Biotherapeutics have partnered to deliver imaging biomarker analysis in a study that...